Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 330

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 330
---
 (a) historical audited financial statements of NorthView as of and for the year ended December31, 2023 and (b) historical unaudited condensed financial statements of NorthView as of and for the nine months ended September30, 2024; •the (a) historical audited financial statements of Profusa as of and for the year ended December31, 2023; and (b) historical unaudited condensed financial statements of Profusa as of and for the nine months ended September30, 2024; and •other information relating to NorthView and Profusa included in this proxy statement/prospectus, including the Merger Agreement and the description of certain terms thereof set forth under the section entitled “ Proposal 1: The Business Combination Proposal.” The unaudited pro forma condensed combined financial information should be read together with the sections titled “ NorthView’s Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “ Profusa’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other financial information included elsewhere in this proxy statement/prospectus. The pro forma condensed combined financial information may not be useful in predicting the future financial condition and results of operations of New Profusa following the Closing. The actual financial position and results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors. 168

Description of the Transactions The Merger and accompanying transactions may be summarized as follows: •NorthView entered into the Merger Agreement with Merger Sub and Profusa, pursuant to which, among other things, (i) Merger Sub will merge with and into Profusa, the separate corporate existence of Merger Sub will cease and Profusa will be the surviving corporation and a wholly owned subsidiary of NorthView, and NorthView will be renamed “Profusa, Inc.”; •Upon the consummation of the Merger, Profusa’s equityholders and holders of convertible promissory notes will receive or have the right to receive an aggregate of 15,500,000shares of New Profusa Common Stock (at a deemed value of $10.00 per share), which, in the case of Profusa Awards, will be shares underlying awards based on New Profusa Common Stock, representing a pre -transactionequity value of Profusa of $155.0 million and (b) the Incentive Equity Value (which is expected to be $29,018,330 for purposes of this proxy statement/prospectus), plus (c